ABL Bio (Korea) Market Value

298380 Stock  KRW 27,050  600.00  2.17%   
ABL Bio's market value is the price at which a share of ABL Bio trades on a public exchange. It measures the collective expectations of ABL Bio investors about its performance. ABL Bio is trading at 27050.00 as of the 23rd of November 2024, a 2.17 percent decrease since the beginning of the trading day. The stock's open price was 27650.0.
With this module, you can estimate the performance of a buy and hold strategy of ABL Bio and determine expected loss or profit from investing in ABL Bio over a given investment horizon. Check out ABL Bio Correlation, ABL Bio Volatility and ABL Bio Alpha and Beta module to complement your research on ABL Bio.
Symbol

Please note, there is a significant difference between ABL Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if ABL Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ABL Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

ABL Bio 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ABL Bio's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ABL Bio.
0.00
10/24/2024
No Change 0.00  0.0 
In 31 days
11/23/2024
0.00
If you would invest  0.00  in ABL Bio on October 24, 2024 and sell it all today you would earn a total of 0.00 from holding ABL Bio or generate 0.0% return on investment in ABL Bio over 30 days. ABL Bio is related to or competes with Genexine. ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurod... More

ABL Bio Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ABL Bio's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ABL Bio upside and downside potential and time the market with a certain degree of confidence.

ABL Bio Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for ABL Bio's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ABL Bio's standard deviation. In reality, there are many statistical measures that can use ABL Bio historical prices to predict the future ABL Bio's volatility.
Hype
Prediction
LowEstimatedHigh
27,04527,05027,055
Details
Intrinsic
Valuation
LowRealHigh
25,72025,72529,755
Details
Naive
Forecast
LowNextHigh
27,18527,19027,194
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
28,22336,09243,960
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as ABL Bio. Your research has to be compared to or analyzed against ABL Bio's peers to derive any actionable benefits. When done correctly, ABL Bio's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in ABL Bio.

ABL Bio Backtested Returns

ABL Bio secures Sharpe Ratio (or Efficiency) of -0.0498, which signifies that the company had a -0.0498% return per unit of return volatility over the last 3 months. ABL Bio exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm ABL Bio's Mean Deviation of 3.55, standard deviation of 4.59, and Variance of 21.1 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.25, which signifies not very significant fluctuations relative to the market. As returns on the market increase, ABL Bio's returns are expected to increase less than the market. However, during the bear market, the loss of holding ABL Bio is expected to be smaller as well. At this point, ABL Bio has a negative expected return of -0.23%. Please make sure to confirm ABL Bio's coefficient of variation, jensen alpha, treynor ratio, as well as the relationship between the standard deviation and total risk alpha , to decide if ABL Bio performance from the past will be repeated in the future.

Auto-correlation

    
  0.03  

Virtually no predictability

ABL Bio has virtually no predictability. Overlapping area represents the amount of predictability between ABL Bio time series from 24th of October 2024 to 8th of November 2024 and 8th of November 2024 to 23rd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ABL Bio price movement. The serial correlation of 0.03 indicates that only 3.0% of current ABL Bio price fluctuation can be explain by its past prices.
Correlation Coefficient0.03
Spearman Rank Test0.17
Residual Average0.0
Price Variance18.3 M

ABL Bio lagged returns against current returns

Autocorrelation, which is ABL Bio stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting ABL Bio's stock expected returns. We can calculate the autocorrelation of ABL Bio returns to help us make a trade decision. For example, suppose you find that ABL Bio has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

ABL Bio regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If ABL Bio stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if ABL Bio stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in ABL Bio stock over time.
   Current vs Lagged Prices   
       Timeline  

ABL Bio Lagged Returns

When evaluating ABL Bio's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of ABL Bio stock have on its future price. ABL Bio autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, ABL Bio autocorrelation shows the relationship between ABL Bio stock current value and its past values and can show if there is a momentum factor associated with investing in ABL Bio.
   Regressed Prices   
       Timeline  

Pair Trading with ABL Bio

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ABL Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ABL Bio will appreciate offsetting losses from the drop in the long position's value.

Moving together with ABL Stock

  0.61207940 Samsung BiologicsPairCorr
  0.9326030 Sk BiopharmaceuticalsPairCorr

Moving against ABL Stock

  0.35182360 Cube EntertainmentPairCorr
The ability to find closely correlated positions to ABL Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ABL Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ABL Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ABL Bio to buy it.
The correlation of ABL Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ABL Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ABL Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ABL Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in ABL Stock

ABL Bio financial ratios help investors to determine whether ABL Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ABL with respect to the benefits of owning ABL Bio security.